Abstract
A superantigen or autoimmunity has been hypothesized to be the main cause of the Kawasakis Disease but the etiology is unknown. Medical literature, epidemiological findings, and some case reports have suggested that mercury may play a pathogenic role. Several patients with Kawasakis Disease have presented with elevated urine mercury levels compared to matched controls. Most symptoms and diagnostic criteria which are seen in children with acrodynia, known to be caused by mercury, are similar to those seen in Kawasakis Disease. Genetic depletion of glutathione S-transferase , a susceptibility marker for Kawasakis Disease, is known to be also a risk factor for acrodynia and may also increase susceptibility to mercury . Coinciding with the largest increase (1985-1990) of thimerosal (49.6% ethyl mercury) in vaccines, routinely given to infants in the U.S. by 6 months of age (from 75μg to 187.5μg), the rates of Kawasakis Disease increased ten times, and, later (1985-1997), by 20 times. Since 1990 88 cases of patients developing Kawasakis Disease some days after vaccination have been reported to the Centers of Disease Control (CDC) including 19% manifesting symptoms the same day. The presented pathogenetic model may lead to new preventive- and therapeutic strategies for Kawasakis disease.
Keywords: Kawasaki's disease, mercury, acrodynia, thimerosal, ethyl mercury, methyl mercury, vaccine, dental amalgam
Current Medicinal Chemistry
Title: Kawasakis Disease, Acrodynia, and Mercury
Volume: 15 Issue: 28
Author(s): J. Mutter and D. Yeter
Affiliation:
Keywords: Kawasaki's disease, mercury, acrodynia, thimerosal, ethyl mercury, methyl mercury, vaccine, dental amalgam
Abstract: A superantigen or autoimmunity has been hypothesized to be the main cause of the Kawasakis Disease but the etiology is unknown. Medical literature, epidemiological findings, and some case reports have suggested that mercury may play a pathogenic role. Several patients with Kawasakis Disease have presented with elevated urine mercury levels compared to matched controls. Most symptoms and diagnostic criteria which are seen in children with acrodynia, known to be caused by mercury, are similar to those seen in Kawasakis Disease. Genetic depletion of glutathione S-transferase , a susceptibility marker for Kawasakis Disease, is known to be also a risk factor for acrodynia and may also increase susceptibility to mercury . Coinciding with the largest increase (1985-1990) of thimerosal (49.6% ethyl mercury) in vaccines, routinely given to infants in the U.S. by 6 months of age (from 75μg to 187.5μg), the rates of Kawasakis Disease increased ten times, and, later (1985-1997), by 20 times. Since 1990 88 cases of patients developing Kawasakis Disease some days after vaccination have been reported to the Centers of Disease Control (CDC) including 19% manifesting symptoms the same day. The presented pathogenetic model may lead to new preventive- and therapeutic strategies for Kawasakis disease.
Export Options
About this article
Cite this article as:
Mutter J. and Yeter D., Kawasakis Disease, Acrodynia, and Mercury, Current Medicinal Chemistry 2008; 15(28) . https://dx.doi.org/10.2174/092986708786848712
DOI https://dx.doi.org/10.2174/092986708786848712 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |

- Author Guidelines
- Editorial Policies
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Allegations from Whistleblowers
- Publishing Ethics and Rectitude
- Increase Visibility Of Your Article
- Archiving Policies
- Reviewer Guidelines
- Guest Editor Guidelines
- Board Recruitment Workflow
- Short Guide for New Editors
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Congenital Heart Disease in Non-Diabetic Large-for-Gestational-Age (LGA) Neonates
Cardiovascular & Hematological Disorders-Drug Targets Deprescribing Antipsychotic Medications in Psychotic Disorders: How and Why?
Current Psychiatry Reviews Probiotics and Oral Health
Current Pharmaceutical Design Graphical Abstracts
Letters in Drug Design & Discovery Blood Pressure as a Therapeutic Target in Stroke
Current Topics in Medicinal Chemistry Fatty Acids: Friends or Foe? Relation Between Dietary Fat and Insulin Sensitivity
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Biomarkers in Cardiomyopathies and Prediction of Sudden Cardiac Death
Current Pharmaceutical Biotechnology Recent Advances in Hematopoietic Stem Cell-Mediated Regeneration
Recent Patents on Regenerative Medicine Why and How We Should Treat Elderly Patients with Hypertension?
Current Vascular Pharmacology Higher Waist Circumference, Fasting Hyperinsulinemia And Insulin Resistance Characterize Hypertensive Patients With Impaired Glucose Metabolism
Endocrine, Metabolic & Immune Disorders - Drug Targets 10 Years of SELDI: What Have we Learnt?
Current Proteomics Nutrigenomic Analysis of Diet-Gene Interactions on Functional Supplements for Weight Management
Current Genomics Neuromodulation of the Perinatal Respiratory Network
Current Neuropharmacology Chemical Constituents of the Genus Prunus and their Medicinal Properties
Current Medicinal Chemistry Clinical Applications of Cardiovascular Magnetic Resonance
Current Pharmaceutical Design Heme Oxygenase-1: A Potential Antihypertensive Target?
Current Hypertension Reviews Nitric Oxide: News from Stem Cells to Platelets
Current Medicinal Chemistry Non-Vitamin K Oral Anticoagulants (NOACs) A Review of Clinical Management and Laboratory Issues
Current Vascular Pharmacology The Pleiotropic Effects of ARB in Vascular Endothelial Progenitor Cells
Current Vascular Pharmacology Pharmacological Approaches of Alzheimer's Disease: An Update
Current Drug Therapy